23300sek
3,6 %
Date:2024-07-24Time:17:29:45Latest report:Q2-2024List:Large CapTicker:VITR
Market Cap:31 559 msekEnterprise Value:32 692 msekNet Sales:3 535 msekEarnings:-3 799 msekEmployees:0ISIN:SE0011205202

Ratios

10-year key figure history for Vitrolife turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Vitrolife with index and moving average MA50 and MA200.

Stockprice:233,00
MA50:184,10
MA200:178,24
Price/MA200:30,7 %
RSI (14):77,8
Price/MA50:26,6 %

Description

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient’s fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

Medical Equipment